[1] 庄红艳,刘珊珊,果伟,等.121例老年精神科药品不良反应报告分析[J].中国药物警戒,2017,14(2):105-108. [2] 李莹, 都丽萍, 李玲玲, 等. 药物对体重的影响[J]. 药物不良反应杂志, 2017, 19(2):121-125. [3] Khalil E, Bruno F, Romain C, et al.Early weight gain predicts later weight gain in depressed patients treated with antidepre-ssants: findings from the METADAP cohort[J].Journal of Affective Disorders, 2018,214(1):22-28. [4] Arterburn D, Sofer T, Boudreau D, et al.Long-Term Weight Change after Initiating Second-Generation Antidepressants[J].Journal of Clinical Medicine,2016,5(4):48-60. [5] Shi Z, Atlantis E, Taylor AW, et al.SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles:results from a 4-year Australian follow-up study[J].BMJ Open,2017,7(8):e016224. [6] Gafoor R, Booth HP, Gulliford MC.Antidepressant utilization and incidence of weight gain during 10 years' follow-up:population based cohort study[J].BMJ, 2018,23(361):k1951. [7] Vandenberghe F, Gholamrezaee M, SaigíMorgui N, et al.Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment[J].Journal of Clinical Psychiatry, 2015, 76(11):e1417. [8] Caleb C, Steven C, Rong Wan, et al.The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C[J].Journal of Clinical Investigation, 2017,127(9):3402-3406. [9] Salvi V, Mencacci C, Barone-Adesi F.The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C[J]. European neuropsychopharmacology,2016, 26(10):1673-1677. [10] Virginio S, Claudio M, Francesco BA.Antidepressant induced weight gain associated with anti-histaminergic activity[J]. BMJ, 2018,7(362):k3222 [11] Salvi V, Barone-Adesi F, D’Ambrosio V,et al. High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder[J].Psychopharmacology (Berl), 2016,233(1):49-56. [12] Serretti A, Mandelli L.Antidepressants and Body Weight: A Comprehensive Review and Meta-Analysis[J]. The Journal of Clinical Psychiatry, 2010, 71(10):1259-1272. [13] Blumenthal SR, Castro VM, Clements CC, et al.An Electronic Health Records Study of Long-Term Weight Gain Following Antidepressant Use[J].JAMA Psychiatry,2014, 71(8):889-896. [14] Gafoor R, Booth HP, Gulliford MC.Antidepressant utilisation and incidence of weight gain during 10 years' follow-up: population based cohort study[J]. BMJ,2018(361):k1951. [15] Serretti A,Mandelli L.Antidepressants and body weight a comp-rehensive review and meta-anaylsis[J].J Clin Psychiatry,2010,71(10):1259-1272. [16] Blumenthal SR, Castro VM, Clements CC, et al.An electronic health records study of long-term weight gain following antidep-ressant use[J]. JAMA Psychiatry,2014,71(8):889-896. [17] Ravindran PP, Zang W, Renukunta S,et al.Effect of comedication of bupropion and other antidepressants on body mass index[J].Ther Adv Psychopharmacol,2015,5(3):158-165. [18] Patten S B.Bupropion confirmed not to cause weight gain in a real-world clinical population[J].Evidence-based mental health,2015,18(2):57-58. [19] lacobsen PL,Harper L.Chrones L,et al.Safety and tolerability of vortioxetine (15 and 20mg)in patients with major depnessive disonder esuls of an open-abel,fexible dose,52-week extension study[J]. Int Clin Psychopharmacol,2015,30(5):255-264. [20] Boulenger LH, Olsen CK.Efficacy and safety of vortioxcetine(Lu AAa1004),15 and 20 mg/day:a randomized, double-blind,placebo-controlled,duloxetine-referenced studv in the acule treatment of adult patients with major depressive disornder[J].Int Clin Peycho pharmacol,2014,29(3):3138-3149. [21] McIntyre RS. The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone[J].Neuropsychiatr Dis Treat,2017(13):2913-2919. [22] Durgam S, Chen C, Migliore R, et al.Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double-blind, placebocontrolled study[J]. Depress Anxiety, 2019,36(3):225-234. [23] Citrome L.Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant-what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?[J]. Int J Clin Pract,2014,68(1):60-82. [24] Ageu LS, Levai CM, Andreescu NI, et al.Modern molecular study of weight gain related to antidepressant treatment: clinical implications of the pharmacogenetic testing[J].Romanian journal of morphology and embryology,2018, 59(1):165-173. [25] Schwartz TL, Meszaros ZS,Khan R,et al. How to control weight gain when prescribing antidepressants[J].Current Psychiatry,2016,15(6):30-32,35-36,39-39,47-48. [26] Jeffrey S,MacDaniels,Thomas L,et al. How to control weight gain when prescribing antidepressants: address diet and exercise first, then consider switching antidepressants or prescribing an adjunctive agent[J]. Current Psychiatry,2016,15(6):31-40. |